Delivery Order SPE2DB20D1109-SPE2DB25FP49L
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a $5,554.37 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561399691 Levorphanol tabs 2mg. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical products from its facility located in Conshohocken, Pennsylvania. The delivery order was awarded on July 3, 2023 under an existing indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,927.24 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,830,114 tablets of 2 mg Levorphanol, a prescription medication, by June 7, 2024. This contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,509.26 to Amerisourcebergen Drug Corporation for 100 tablets of 2 mg levorphanol. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is August 7-8, 2023. Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the Defense Logistics Agency under this small purchase order as a division of its parent company,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,202,532 units of the prescription medication Levorphanol 2 mg tablets in quantities of 100 per bottle. The contract has a firm fixed price of $1,984.51 and a completion date of May 12, 2025. This award is not associated with a set-aside program and appears to be an...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levorphanol Tablets 2mg, a prescription medication, with a ceiling value of $1,756.73 and a period of performance through May 21, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,019.52 firm fixed-price delivery order is for the supply of 4564437604 LEVORPHANOL 2 MG TABLET 100S, with a performance period through April 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $7,240 delivery order to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract, designated as a non-competitive award with no set-aside provisions, represents a child delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $179,628.39 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP49LDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Levorphanol 2 mg tablets (100-count units) with a ceiling value of $2.8K. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and represents a non-competitive set-aside award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies. The company's DLA IDC enables it to supply diverse medications and medical commodities to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. This specific Levorphanol delivery order reflects the company's role as a reliable supplier of pain management pharmaceuticals and specialty medications within the DLA's pharmaceutical prime vendor network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/31/25 |